Sign inJoin waitlistJoin the waitlist

Aaron Gerds

Deputy Associate Director for Clinical Research, Case Comprehensive Cancer Center · Case Western Reserve University

Credentials: · · · · · ·

History

Case Western Reserve University
Present

University of Washington Medical Center - Montlake
2012–2013
Internal Medicine
Loyola University Medical Center
2007–2010
Loyola University
Loyola University Chicago Stritch School of Medicine
2002–2006
Hope College
1998–2002

Research

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial
JAMA Oncology · 2018 · 347 citations
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet · 2023 · 180 citations
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Blood · 2015 · 165 citations

Ronald Sobecks
50 papers
Matt Kalaycio
47 papers
Betty Hamilton
42 papers
NM
Navneet Majhail
35 papers
Mikkael Sekeres
33 papers
Ruben Mesa
33 papers
Sudipto Mukherjee
33 papers
Hetty Carraway
26 papers
BP
Brad Pohlman
25 papers
Robert Dean
25 papers
Anjali Advani
24 papers
Deepa Jagadeesh
24 papers

Grants

Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
National Cancer Institute · UG1
Contact PI · $11.1M · Case Western Reserve University
2019–2032
Case Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $3.3M · Case Western Reserve University
1997–2025
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
National Cancer Institute · U10
PI · $1.2M · Case Western Reserve University
2014–2019

Clinical trials

Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms
Principal investigator · Withdrawn · Phase 1, Phase 2
Case Comprehensive Cancer Center
2024
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Study chair · Recruiting · Phase 2
Icahn School of Medicine at Mount Sinai
2023–2028
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Site PI · Recruiting · Phase 3
Takeda
2026–2034
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Site PI · Recruiting · Phase 2
Karyopharm Therapeutics Inc
2024–2028